Bijing Xiao

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangdong Provincial Center for Disease Control and Prevention, State Key Laboratory of Oncology in South China

发表论文 11 篇 · 总被引 131 次 · h-index 5

代表论文

• Baseline and early changes in the neutrophil–lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapy (2023 · International Immunopharmacology · 被引 69)
• Sarcopenia defined by skeletal muscle mass index at the third lumbar vertebra is a prognostic factor for extensive-stage small cell lung cancer patients: a retrospective study (2022 · Journal of Thoracic Disease · 被引 16)
• Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation (2024 · Journal of Translational Medicine · 被引 15)
• Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysis (2023 · Cancer Immunology Immunotherapy · 被引 11)
• Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers (2024 · Journal of Translational Medicine · 被引 7)
• First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis (2025 · MedComm · 被引 5)